Does the β2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?

Circulation

Volumn 112, Issue 9 SUPPL., 2005, Pages

  Tsuneyoshi, Hiroshi ^a   Oriyanhan, Wnimunk ^a   Kanemitsu, Hideo ^a   Shiina, Reiko ^a   Nishina, Takeshi ^a   Matsuoka, Satoshi ^a   Ikeda, Tadashi ^a   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy; Heart failure; Heart assist device; Inotropic agents; Receptors, adrenergic, beta

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CASPASE 3; CLENBUTEROL; INOTROPIC AGENT; ISOENZYME; ISOPRENALINE; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; SARCOPLASMIC RETICULUM ADENOSINE TRIPHOSPHATASE (CALCIUM) 2A; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CASP3 PROTEIN, RAT; CASPASE; ISOPROTEIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATROPHY; CALCIUM HOMEOSTASIS; CELL PROTECTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFECT; DRUG RESPONSE; GENE EXPRESSION; GENE SWITCHING; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE ATROPHY; HEART MUSCLE POTENTIAL; HEART MUSCLE RECOVERY; HEART MUSCLE TENSION; HEART PAPILLARY MUSCLE; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HETEROTOPIC TRANSPLANTATION; INOTROPISM; MECHANICAL UNLOADING; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DOWN REGULATION; DRUG SCREENING; ENZYME INDUCTION; GENE EXPRESSION REGULATION; GENETICS; HEART; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE; ISOGRAFT; LEWIS RAT; MALE; MECHANICAL STRESS; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; ATROPHY; CALCIUM-TRANSPORTING ATPASES; CASPASE 3; CASPASES; CLENBUTEROL; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HEART; HEART TRANSPLANTATION; HEART VENTRICLES; ISOPROTERENOL; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOSIN HEAVY CHAINS; ORGAN SIZE; PAPILLARY MUSCLES; PROTEIN ISOFORMS; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; STRESS, MECHANICAL; TRANSPLANTATION, HETEROTOPIC; TRANSPLANTATION, ISOGENEIC; VENTRICULAR FUNCTION, LEFT;

EID: 24644522768     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.525097     Document Type: Article

References (25)

1. Hetzer R, Mueller J, Weng Y, Wallukat G, Spiegelsberger S, Loebe M. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg. 1999;68:742-749.
2. Heerdt PM, Holmes JW, Cai B, Barbone A, Madigan JD, Reiken S, Lee DL, Oz MC, Marks AR, Burkhoff D. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 2000;102:2713-2719.
3. Mancini DM, Beniamovitz A, Levin H, Catanese K, Flannery M, DiTullio M, Savin S, Elena C, Rose E, Oz M. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998;98:2383-2389.
4. Kinoshita M, Takano H, Taenaka Y, Mon H, Takaichi S, Noda H, Tatsumi E, Yagura A, Sekii H, Akutsu T. Cardiac disuse atrophy during LVAD pumping. ASAIO Trans. 1988;34:208-212.
5. Hon JK, Yacoub MH. Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg. 2003;75:S36-S41.
6. Wong K, Boheler KR, Bishop J, Petrou M, Yacoub MH. Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features. Cardiovasc Res. 1998;37:115-122.
7. Wong K, Boheler KR, Petrou M, Yacoub MH. Pharmacological modulation of pressure-overload cardiac hypertrophy. Circulation. 1997;96:2239-2246.
8. Ahmet I, Krawczyk M, Heller P, Moon C, Lakatta EG, Talan MI. Beneficial effects of chronic pharmacological manipulation of β-adreno-receptor subtype signaling in rodent dilated ischemie cardiomyopathy. Circulation. 2004;110:1083-1090.
9. Tsuneyoshi H, Oriyanhan W, Kanemitsu H, Shiina R, Nishina T, Ikeda T, Nishimura K, Komeda M. Heterotopic transplantation of failing rat heart as a model of LV mechanical unloading toward recovery. ASAIO J. 2005;51:116-120.
10. Tsuneyoshi H, Nishina T, Nomoto T, Kanemitsu H, Kawakami R, Unimonh O, Nishimura K, Komeda M. Atrial natriuretic peptide helps prevent late remodeling after left ventricular aneurysm repair. Circulation. 2004;110(suppl I):I-174-I-179.
11. Maybaum S, Epstein S, Beniaminovitz A, Di Tullio M, Oz M, Bergmann SR, Mancini D. Partial loading of the left ventricle during mechanical assist device support is associated with improved myocardial function, blood flow and metabolism and increased exercise capacity. J Heart Lung Transplant. 2002;21:446-454.
12. Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res. 1989;65:657-670.
13. Korecky B, Masika M. Direct effect of increased hemodynamic load on cardiac mass. Circ Res. 1991;68:1174-1178.
14. Depre C, Davies PJA, Taegtmeyer H. Transcriptional adaptation of the heart to mechanical unloading. Am J Cardiol. 1999;83:58H-63H.
15. Miyamoto MI, Monte F, Schmidt U, DiSalvo TS, Kang ZB, Matsui T, Guerrero JL, Gwathmey JK, Rosenzweig A, Hajjar RJ. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc Natl Acad Sci U S A. 2000;97:793-798.
16. Terracciano CMN, Hardy J, Birks EJ, Khaghani A, Banner NR, Yacoub MH. Clinical recovery from end-stage heart failure using left-ventricular assist device and pharmacological therapy correlates with increased sarcoplasmic reticulum calcium content but not with regression of cellular hypertrophy. Circulation. 2004;109:2263-2265.
17. Depre C, Shipley GL, Chen W, Han Q, Doenst T, Moore ML, Stepkowski S, Davies P, Taegtmeyer H. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med. 1998;4:1269-1275.
18. Schena S, Kurimoto Y, Fukada J, Tack I, Ruiz P, Pang M, Striker LJ, Aitouche A, Pham SM. Effects of ventricular unloading on apoptosis and atrophy of cardiac myocytes. J Surg Res. 2004;120:110-126.
19. Nicholson DW, Ali A, Thornberry NA, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Seulson ME, Yamin TT, Yu VL, Miller DK. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995:376:37-43.
20. 2-Adrenoceptor activation inhibits Shiga toxin2-induced apoptosis of renal tubular epithelial cells. Biochem Pharm. 2003;66:343-353.
21. Brouri F, Findji L, Mediani O, Mougenot N, Hanoun N, Naour GL, Hamon M, Lechat P. Toxic cardiac effects of cathechalamines: role of adrenoceptor downregulation. Eur J Pharmacol. 2002;456:69-75.
22. 2+ handling and inotropy in postinfarcted rat myocardium. Eur J Pharmacol. 2003;471:41-47.
23. Lavoie JL, Calderone A, Beliveau L. A farnesyltrausferase inhibitor attenuated β-adrenergic receptor downregulation in rat skeletal muscle. Am J Physiol Regulatory Int Comp Physiol. 2002;282:R317-R322.
24. Tevaearai HT, Koch WJ. Modecular restoration of β-adrenergic receptor signaling improves contractile function of failing hearts. Trends Cardiovasc Med. 2004;14;252-256.
25. Petrou M, Clarke S, Morrison K, Bowles C, Dunn M, Yacoub M. Clenbuterol increases stroke power and contractile speed of skeletal muscle for cardiac assist. Circulation. 1999;99:713-720.